We further found that overexpression of FOXD1 generally predicts poor prognosis in tumors with high FOXD1 expression, such as ACC, READ, MESO, LGG, UVM, PAAD, KIRC, HNSC, SARC, and BLCA. Here, FOXD1 is linked to bladder transitional cell carcinoma.